Literature DB >> 933547

Prognostic significance of peripheral lymphocyte counts and carcinoembryonic antigens in colorectal carcinoma.

U S Kim, A E Papatestas, A H Aufses.   

Abstract

An association between pretreatment lymphocyte counts and 5-year prognosis was noted in colorectal cancer. Among 188 patients with 5-year follow-up significant difference in survival rates in relation to lymphocyte counts was noted: 61% for patients with counts greater than 2,000/cm, 30% for those with counts less than 1,000/cmm, and 58% for the intermediate group. Similar differences were also noted within groups with Dukes' B and C lesions and in elderly patients. Highly significant differences were noted in women. Those with Dukes' B and C lesions with counts greater than 2,000/cmm had an 81% survival rate, compared to 50% for those with lower counts X2 = 6.81 P LESS THAN 0.01. Women had significantly higher lymphocyte counts and higher survival rates than men. An inverse correlation was noted between pretreatment lymphocytes and simultaneously determined carcinoembryonic antigens. These observations indicate that lymphocyte counts may be of prognostic value in colorectal cancer when used in association with carcinoembryonic antigens.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 933547     DOI: 10.1002/jso.2930080312

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  4 in total

1.  Screening for liver metastases from colorectal cancer with carcinoembryonic antigen and alkaline phosphatase.

Authors:  P I Tartter; G Slater; I Gelernt; A H Aufses
Journal:  Ann Surg       Date:  1981-03       Impact factor: 12.969

2.  Pretreatment serum markers and lymphocyte response to interleukin-2 therapy.

Authors:  L Fumagalli; P Lissoni; G Di Felice; S Meregalli; G Valsuani; S Mengo; F Rovelli
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

3.  Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer.

Authors:  Chi Hwan Choi; Won Dong Kim; Sang Jeon Lee; Woo-Yoon Park
Journal:  Radiat Oncol J       Date:  2012-09-30

4.  Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial.

Authors:  Michele Guida; Alessandra Ravaioli; Vanna Chiarion Sileni; Antonella Romanini; Roberto Labianca; Antonio Freschi; Salvatore Brugnara; Addolorata Casamassima; Vito Lorusso; Oriana Nanni; Ruggero Ridolfi
Journal:  J Transl Med       Date:  2003-12-22       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.